By Dr John Walter Frew

Journal articles

Venugopal SS; Yan H; Frew JW; Tran K; Melbourne W; Nelson J; Sturm M; Fogarty F; Marinkovich P; Igawa S; Ishida-Yamamoto A; Murrell DF, 2010, 'TRIAL OF FIBROBLAST CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 18, pp. A74 - A74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279454700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Martin LK; Nijsten T; Murrell DF, 2010, 'Erratum: Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument (British Journal of Dermatology (2009) 161 (1323-1330))', British Journal of Dermatology, 162, pp. 701, http://dx.doi.org/10.1111/j.1365-2133.2010.09642.x

Purdie KJ; Pourreyron C; Fassihi H; Cepeda-Valdes R; Frew JW; Volz A; Weissenborn SJ; Pfister H; Proby CM; Bruckner-Tuderman L; Murrell DF; Salas-Alanis JC; McGrath JA; Leigh IM; Harwood CA; South AP, 2010, 'No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma', Journal of Investigative Dermatology, 130, pp. 2853 - 2855, http://dx.doi.org/10.1038/jid.2010.243

Frew JW; Murrell DF, 2010, 'Quality of Life Measurements in Epidermolysis Bullosa: Tools for Clinical Research and Patient Care', Dermatologic Clinics, 28, pp. 185 - 190, http://dx.doi.org/10.1016/j.det.2009.10.019

Frew JW; Martin LK; Nijsten T; Murrell DF, 2009, 'Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument', British Journal of Dermatology, 161, pp. 1323 - 1330, http://dx.doi.org/10.1111/j.1365-2133.2009.09347.x

Frew JW, 2009, 'Performing surgery with a single electron: Electrosurgery and quantum mechanics', ANZ Journal of Surgery, 79, pp. 680 - 682, http://dx.doi.org/10.1111/j.1445-2197.2009.05051.x

Nading M; Lahmar J; Frew J; Ghionis N; Hanley M; Welch A; Murrell DF, 2009, 'A ski and adventure camp for young patients with severe forms of epidermolysis bullosa', Journal of the American Academy of Dermatology, 61, pp. 508 - 511

Frew J; Martin L; Murrell DF, 2008, 'Development of a quality of life measure specific for epidermolysis bullosa', Journal of Investigative Dermatology, 128, pp. S80 - S80

Frew J; Martin L; Murrell DF, 2008, 'Quality of life evaluation in epidermolysis bullosa', Journal of the American Academy of Dermatology, 58, pp. AB81 - AB81

Frew J; Martin L; Murrell DF, 2008, 'Quality of life evaluation in epidermolysis bullosa: Development of the QOLEB questionnaire', Journal of Investigative Dermatology, 128, pp. 1607 - 1607

Frew J; Mallick U; Perros P, 2007, 'A patient with asymmetric parotid uptake on a diagnostic iodine-131 scan during thyroid cancer follow-up', THYROID, 17, pp. 801 - 802, http://dx.doi.org/10.1089/thy.2006.0309

Henderson NC; Pollock KJ; Frew J; Mackinnon AC; Flavell RA; Davis RJ; Sethi T; Simpson KJ, 2007, 'Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure', GUT, 56, pp. 982 - 990, http://dx.doi.org/10.1136/gut.2006.104372

Frew J; Mort F, 1907, 'SOUTHERN HIGHLANDS FROM GLASGOW', SCOTTISH GEOGRAPHICAL MAGAZINE, 23, pp. 367 - 372, http://dx.doi.org/10.1080/00369220708733767

Frew J; Mort F, 1906, 'THE SOUTHERN HIGHLANDS FROM DUMGOYN', SCOTTISH GEOGRAPHICAL MAGAZINE, 22, pp. 322 - 324, http://dx.doi.org/10.1080/14702540608554666

Mort F; Frew J, 1906, 'THE SOUTHERN HIGHLANDS FROM GOUROCK', SCOTTISH GEOGRAPHICAL MAGAZINE, 22, pp. 435 - 438, http://dx.doi.org/10.1080/00369220608733658

Conference Papers

Orenstein LAV; Shi VY; Lev-Tov H; Prens E; Ingram JR; Frew JW; Fujita H; Rolleri R; Lambert J; Crater C; Bechara FG; Davis L; Szepietowski JC, 2025, '2-year Impact of Bimekizumab on HSSQ Skin Pain in moderate to severe HS: Data from BE HEARD EXT', in JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, WILEY, pp. 133 - 133

Orenstein LA; Shi VY; Lev-Tov H; Prens E; Ingram JR; Frew JW; Fujita H; Rolleri R; Lambert J; Crater C; Bechara FG; Davis L; Szepietowski JC, 2025, '2-year impact of bimekizumab on HSSQ skin pain in moderate to severe HS: data from BE HEARD EXT', in JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, WILEY

Tzellos T; Sayed CJ; Gottlieb AB; Becherel P-A; Kirby B; Asai J; Frew JW; Pansar I; Tilt N; Rolleri R; Porter ML, 2025, 'Bimekizumab impact on draining tunnel reduction over 2 years in moderate to severe hidradenitis suppurativa: Results from BE HEARD EXT', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB137 - AB137

Sayed CJ; Kirby B; Frew JW; Porter ML; Ingram JR; Prens E; Charrow AP; Gooderham MJ; Savage L; Reich K; Bechara FG, 2025, 'IHS4-100 responses and other IHS4 outcomes with the IL-17A-and IL-17F-inhibiting Nanobody sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 24 results from the Phase 2 MIRA trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB221 - AB221

Porter ML; Kirby B; Krueger JG; Bechara FG; Frew JW; Sayed CJ; Pinter A; Szepietowski JC; Bertolini M; Reich K; Kimball AB, 2025, 'Resolution of deep dermal inflammatory lesions with the Nano-body sonelokimab in moderate-to-severe hidradenitis suppurativa (HS): preclinical results and outcomes from the Phase 2 MIRA trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER

Frew J; Flora A; Pham J; Woods J; Radzieta M; Dickson H; Malone M, 2025, 'The Clinical and Molecular Response of Pyoderma Gangrenosum to Interleukin 23 Blockade: Result from a proof-of-concept open-label clinical trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB313 - AB313

van der Zee HH; Kirby B; Bechara FG; Jemec GBE; Frew JW; Rolleri R; Joshi P; Pansar I; Tilt N; Sayed CJ, 2024, 'Bimekizumab impact on lesion count by anatomical region in moderate to severe hidradenitis suppurativa: Results to week 48 from BE HEARD I & II', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Zouboulis CC; Kirby JS; Tzellos T; Khattri S; Alavi A; Podda M; del Marmol V; Spelman L; Rolleri R; Joshi P; Davis L; Pansar I; Frew JW, 2024, 'IHS4 outcomes with bimekizumab in patients with moderate to severe hidradenitis suppurativa: Pooled results from the BE HEARD I & II phase 3 trials', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Kirby B; Frew JW; Porter MJ; Bechara FG; Ingram JR; Prens EP; Charrow AP; Sayed CJ; Brennan N; Godwood A; Attar N; Cullen E; Reich K, 2024, 'The IL-17A-and IL-17F-inhibiting Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 12 International Hidradenitis Suppurativa Severity Score System (IHS4) results from the phase 2 MIRA trial', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Zarroug M; Shaheen A; Mohammed A; Elgendy M; Burns A; AlHilali M; Vanderputten M; Azzabi A; Chandler R; Frew J; Hayhurst H; Jackson M; Pedley I; Pearson R; Jiang X, 2023, 'Brain directed therapy followed by systemic treatment in metastatic renal cell carcinoma', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, AUSTRIA, Vienna, pp. S894 - S894, presented at Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), AUSTRIA, Vienna, 12 May 2023 - 16 May 2023

Flora A; Jepsen R; Kozera E; Woods J; Cains G; Radzieta M; Malone M; Frew JW, 2023, 'Human dermal fibroblasts and mast cell populations are altered in hidradenitis suppurativa, with epithelial-mesenchymal-transition signals ameliorated by spleen tyrosine kinase antagonism.', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Tokyo, pp. S227 - S227, presented at 1st International Societies for Investigative Dermatology Meeting, JAPAN, Tokyo, 12 May 2023 - 13 May 2023

Paton E; Fogarty G; Murrell D; Frew J, 2023, 'A proposed phase I trial evaluating Volumetric Modulated Arc Therapy ( VMAT) radiotherapy (RT) in patients with recalcitrant Hidradenitis Suppurativa (HS)', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 51 - 52

Kozera E; Flora A; Stewart T; Gill K; De la Vega MA; Frew J, 2023, 'Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with malassezia-specific immunoglobulin e levels mirroring cli', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 12 - 12

Flora A; Frew J, 2023, 'Hidradenitis Suppurativa: Clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism -A Prospective Cohort Study', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 15 - 15

Pham J; Frew J, 2023, 'Resident cutaneous memory T-cells: A review of their role in modulating chronic inflammatory dermatoses and potential as therapeutic targets', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 80 - 81

Jepsen R; Flora A; Kozera E; Frew JW, 2023, 'SYK antagonism in hidradenitis suppurativa demonstrates clinical efficacy with grearter response in B-cell predominant disease: Results of a open-label, proof-of-concept phase 2 clinical trial', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. B15 - B15

Flora A; Frew J; Woods J, 2023, 'Tick bite induced meat allergy: A presentation of two cases and review of the literature', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 57 - 58

Pham JP; Glasenhardt K; Garg A; Frew JW, 2022, 'Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and ‘number needed to be exposed’', in Journal of the European Academy of Dermatology and Venereology, pp. e1004 - e1006, http://dx.doi.org/10.1111/jdv.18403

Kuhnl A; Mikhaeel G; Kirkwood AA; Menne TF; Frew J; Tholouli E; Patel A; Besley CM; Beasley MJ; Latif AL; O'Rourke N; Nicholson E; Alexander E; Chaganti S; Stevens AM; Marzolini MAV; Johnson RJ; Sanderson R; Sivabalasingham S; Roddie C, 2021, 'Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, pp. S130 - S130

Tree AC; Hall E; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Brand DH; Chan A; Dayes IS; Brown S; Pugh J; Burnett S; Dufton A; Griffin C; Mahmud M; Naismith O; van As N, 2021, 'Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S197 - S197, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000709667200220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jackson M; Hannaway N; Burns A; Pearson R; Chandler R; Frew J; Azzabi A; Jiang X, 2021, 'High dose palliative radiotherapy in bladder cancer - A single centre experience from the UK', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S1152 - S1153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000709667203302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Navrazhina K; Renert-Yuval Y; Frew J; Grand D; Garcet S; Krueger JG, 2021, 'Blood analysis uncovers novel inflammatory, oncologic and cardiovascular biomarkers in psoriasis and Hidradenitis Suppurativa', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. S122 - S122, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800701&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams S; Navrazhina K; Frew J; Garcet S; Krueger JG, 2021, 'Vascularization in the deep dermis of hidradenitis suppurativa lesions', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. S121 - S121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800698&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McCallum H; Wyatt JJ; Frew J; Walker C; Richmond N; Wilkinson M; Driver S; Pilling K; Rachel L B; West S; Pearson RA, 2020, 'Real-life experiences of an MR-Only prostate radiotherapy pathway with MR-CBCT soft-tissue matching', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S1001 - S1002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000648572703314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Navrazhina K; Garcet S; Krueger J, 2020, 'Targeted IL-17RA antagonism ameliorates histological and transcriptomic features of hidradenitis suppurativa: A proof of concept study', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, ELECTR NETWORK, pp. S115 - S115, presented at Virtual Conference of the Society-for-Investigative-Dermatology (SID ), ELECTR NETWORK, 13 May 2020 - 16 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000554564400719&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wyatt J; Pearson RA; Frew J; Walker C; Richmond N; Wilkinson M; Wilkes K; Driver S; West S; Pilling K; Brooks RL; Ainslie D; Wilkins E; McCallum HM, 2020, 'Evaluation of first 20 patients treated with MR-Only prostate radiotherapy with MR-CBCT matching', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S265 - S265

Pearson R; Samuel R; McCallum H; Frew J; Howell E; Maxwell R, 2019, '18F-Choline-PET-CT to guide simultaneous integrated boost in prostate cancer', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, ITALY, Milan, pp. S1115 - S1115, presented at 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), ITALY, Milan, 26 April 2019 - 30 April 2019, http://dx.doi.org/10.1016/S0167-8140(19)32451-X

Wyatt J; Frew J; Henry A; Murray L; Pearson R; McNeil A; Johnstone E; Speight R; McCallum H, 2019, 'Investigating a new MR sequence combined with radiologist training for prostate delineation', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, ITALY, Milan, pp. S1124 - S1125, presented at 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), ITALY, Milan, 26 April 2019 - 30 April 2019, http://dx.doi.org/10.1016/S0167-8140(19)32467-3

Pearson R; Jiang X; Atkinson S; Cumming S; Burns A; Frew J; McMenemin R; Pedley I; Azzabi A, 2019, 'Radium-223 treatment in Metastatic Prostate Cancer: Prognostic Factors: Real-world Outcome', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, ITALY, Milan, pp. S855 - S855, presented at 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), ITALY, Milan, 26 April 2019 - 30 April 2019, http://dx.doi.org/10.1016/S0167-8140(19)32004-3

Jiang XY; Atkinson S; Cumming S; Burns A; Pearson R; Frew J; McMenemin R; Azzabi A; Leaning D; Pedley I, 2019, 'Radium-223 therapy in symptomatic metastatic castrate resistant prostate cancer (mCRPC) - sequential use post-abiraterone/prednisolone', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. E10 - E11, http://dx.doi.org/10.1016/j.clon.2019.09.012

Watson N; Fatah S; Bacon C; Frew J; Weatherhead S, 2018, 'A rare cause of blistering: aggressive bullous cutaneous T-cell lymphoma', in BRITISH JOURNAL OF DERMATOLOGY, WILEY, SCOTLAND, Edinburgh, pp. 24 - 24, presented at 98th Annual Meeting of the British-Association-of-Dermatologists (BAD), SCOTLAND, Edinburgh, 03 July 2018 - 05 July 2018

Tatian A; Slape D; Frew J, 2018, 'Pachyonychia congenita tarda: A systematic review of case reports', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 116 - 117, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Choy B; Woods JA; Satchell AC, 2018, 'Secukinumab: An emerging successful therapy for pityriasis rubra pilaris: An Australian case series', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wyatt J; Frew J; Henry A; Murray L; Pearson R; Johnstone E; Speight R; McCallum H, 2018, 'Investigating a new MR sequence for prostate delineation for radiotherapy', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, SPAIN, Barcelona, pp. S1172 - S1172, presented at 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), SPAIN, Barcelona, 20 April 2018 - 24 April 2018, http://dx.doi.org/10.1016/S0167-8140(18)32437-X

Pearson R; Pieniazek P; Thelwall P; Maxwell R; Plummer R; Frew J, 2018, 'Diffusion-weighted MRI for Early Response Assessment in the Treatment of Bladder Cancer', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. 192 - 192

Back to profile page